SAEYOUNG LEE: Open Payments
NPI 1316609464 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,380 in 63 payments from 18 companies in 2025. Trend: 2023 $1,986 · 2024 $1,465 · 2025 $1,380
Food & beverage: $1,380
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $253 |
| UCB, Inc. | 17 | $189 |
| AstraZeneca Pharmaceuticals LP | 4 | $160 |
| Amgen Inc. | 10 | $143 |
| KYOWA KIRIN, INC. | 1 | $127 |
| GlaxoSmithKline, LLC. | 5 | $113 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Organon LLC | 2 | $51 |
| Mallinckrodt Hospital Products Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
Products named: TREMFYA, Bimzelx, CRYSVITA, BENLYSTA, OTEZLA, ORENCIA, ACTHAR, SAPHNELO.
Industry payments across GA — which companies pay providers there.
